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„Anemia of inflammatory disease“ in the cat – a clinical study 
Anemia of inflammatory disease (AID) is the most common anemia in humans and animals 
but has been investigated in the cat only in a few, mainly experimentally studies. The 
pathogenesis in AID is multifactorial, resulting from decreased iron availability, a decline in 
erythrocyte survival time and a decreased response to anemia. The aim of this clinical study 
was to describe the course of AID, laboratory parameters important for the diagnosis and 
pathogenesis of AID and the therapy of 26 cats with inflammatory diseases (abscess [a] 
n=13, pyothorax [pt] n=7, pyometra [pyo] n=1, mycobacterial infection n=1, fat necrosis [fn] 
n=4). Cats with a positive FeLV/FIV test result, with a neoplasia, nephro- or hepatopathy as 
well as animals with blood loss anemia were excluded from the study. A complete blood cell 
count, clinical chemistry, serum concentrations of erythropoietin (EPO), iron and ferritin, the 
total iron binding capacity (TIBC), the acute-phase-proteins α1-AGP and haptoglobin, the 
osmotic fragility (OF) of erythrocytes as well as a direct Coombs’ test were performed. 
The hct was monitored over 3-51 days (mean 15.5, median 11). Eleven of 26 cats were 
anemic on presentation, whereas 12 cats developed anemia during hospitalization. Three 
other cats did not develop anemia; the hematocrit (Hct) of 2 cats decreased within the 
reference range (pt, fn) and an increase was noted in one cat (a). The anemia was 
predominantly mild (47.9%) to moderate (39.1%), but in some cases (13%) also severe. The 
Hct decreased – depending on the timepoint of measurement – from the 2nd to 7th day after 
hospitalization and decreased further throughout a period of 3-16 days. In 6 cats the Hct 
values were within the reference range 2-18 days after surgery (a), 18 days after start of the 
therapy (pt) and 10-19 days after surgery (fn). On the other hand 17 of the cats remained 
anemic over various timespans: up to 29 days (a), up to 16 days (pt), up to 40 days (pyo) or 
51 days (mycobacterial infection) and 15 days (fn). In 95.6% of patients the anemia was 
mainly normocytic, whereas a constant microcytic anemia was present in one cat (4,4%). A 
temporary mild macrocytosis occured in 3 cats (13%). In all patients, anemia was 
predominantly normochromic with only a few measurements of hypo- or hyperchromic 
anemia (26.1% and 21.7%). In 73.9% of cases the anemia was non-regenerative, whereas in 
6 cats (26.1%) a mild regeneration (43,200-84,450 aggregated reticulocytes/µl) was noticed. 
Leukocytosis (18.9-150.0×109/l) was observed in 22 of 26 and a left shift in 12 of 19 patients, 
however the cats without leukocytosis also developed an AID. The acute-phase-protein α1-
AGP was elevated in all examined 19 patients over a period of 7 days prior to 14 days after 
surgery. Haptoglobin however was elevated in 16 of 19 cats and within the reference range 
in 3 animals 5, 7 and 14 days after beginning of the therapy. Neither the Hct value nor the 
number of aggregated reticulocytes showed an inverse correlation with the number of 
leukocytes, the α1-AGP or haptoglobin concentration. Conspicuous results were a lowered 
albumin/globulin-ratio in 92.3% of the patients as well as hypoalbuminemia (84.6%) and 
hyperglobulinemia (76.9%). These results agree with abnormalities seen in the acute-phase-
reaction. 
As opposed to documentations on serum iron levels for humans and dogs cats rarely (13%) 
had lowered serum iron levels. However 47.8% of the cats had levels within the lower third of 
the reference range. As TIBC was often (39.1%) lowered or within the lower third of the 
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reference range (47.8%) and was never elevated and the ferritin concentration was 
predominantly (60.9%) elevated and never lowered, it seems that these parameters are 
helpful for the diagnosis of the AID and for the differentiation from an iron deficiency anemia. 
The positive Coombs’ test in 2 of 10 examined cats (pt: IgG positive, mycobacterial infection: 
C3b positive), a mild hyperbilirubinemia in 6 of 26 cats (23.1%) and an elevated OF of 
erythrocytes in 2 of 17 animals (11.8%) led to the assumption of a shortening of the 
erythrocyte survival time. 
In spite of a mild to moderate anemia, EPO concentrations of 30.8% of the cats were within 
the reference range and only slightly elevated in 61.5% of the animals. There was no inverse 
correlation between the EPO concentrations and the parameters of anemia (hct, hemoglobin 
concentration, number of erythrocytes). Therefore an inadequate EPO production is an 
important pathomechanism of AID in the cat. Furthermore the bone marrow regeneration 
response to produced EPO seems to be insufficient, because anemia was non-regenerative 
in 6 of 8 cats with slightly elevated EPO concentrations. Only one cat (7.7%) had high EPO 
concentrations and had to be euthanized because of its poor condition. A high EPO, as with 
AID in humans, may be associated with a negative prognosis. 
A specific therapy of the anemia is usually not necessary because AID in humans and dogs 
is normally mild. In most animals it was possible to resolve the anemia by treating the 
underlying disease. However, 3 cats needed 2-4 blood transfusions either because of the 
severity of anemia or for stabilisation before anesthesia. 
In this study it was shown that feline anemia of inflammatory disease is usually mild to 
moderate, non-regenerative and normocytic, normochromic. An inflammation, however, may 
also result in a severe, transfusion-dependent anemia, so that frequent Hct controls are 
indicated in feline patients with AID. As in humans the pathogenesis of AID seemed to be 
multifactorial, due to evidence of a shortened erythrocyte survival time, an iron sequestration 
and an inadequate production of EPO. To this point in time it has not been studied whether 
EPO, which is used to treat human AID, might be useful in cats with AID. 
 
 
